本页面由Tiger Trade Technology Pte. Ltd.提供服务

Regenxbio Inc

14.97
+0.38002.60%
盘后14.970.00000.00%16:10 EST
成交量:59.80万
成交额:901.18万
市值:7.58亿
市盈率:-4.32
高:15.41
开:14.74
低:14.61
收:14.59
52周最高:15.41
52周最低:5.04
股本:5,062.31万
流通股本:4,142.31万
量比:0.69
换手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):-3.4644
每股收益(LYR):-4.5871
净资产收益率:-76.88%
总资产收益率:-18.54%
市净率:4.69
市盈率(LYR):-3.26

数据加载中...

2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/18

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/02

重要事件披露

Form 8-K - Current report
2023/08/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/06

重要事件披露

Form 8-K - Current report
2023/05/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/05/03

重要事件披露

8-K - Current report